HPV-specific binding molecules

Provided are binding molecules, such as TCRs or antigen binding fragments thereof and antibodies and antigen-binding fragments thereof, such as those that recognize or bind human papilloma virus (HPV) 16, including HPV 16 E6 and HPV 16 E7. Also provided are engineered cells containing such binding m...

Full description

Saved in:
Bibliographic Details
Main Authors Koppstein, David, Goldfless, Stephen, Johnstone, Timothy, Sather, Blythe, Timberlake, Sonia, Jiang, Yue, Toy, Dean Y, Sissons, James, Belmont, Brian, Nguyen, Hieu, Ebens, Allen, Peper, Haley, Croft, Alexandra, Brandt, Cameron
Format Patent
LanguageEnglish
Published 31.08.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided are binding molecules, such as TCRs or antigen binding fragments thereof and antibodies and antigen-binding fragments thereof, such as those that recognize or bind human papilloma virus (HPV) 16, including HPV 16 E6 and HPV 16 E7. Also provided are engineered cells containing such binding molecules, compositions containing the binding molecules or engineered cells, and methods of treatment, such as administration of the binding molecules, engineered cells, or compositions.
Bibliography:Application Number: AU20170338827